APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medical Nuclide Products

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Medical Nuclide Products Industry Growth and Trends Forecast to 2032

23 December 2025124 pages

Choose your research edition.

Industry ResearchMedical Nuclide Products Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Nuclide Products Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Medical Nuclide Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Nuclide Products Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Nuclide Products Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

According to APO Research, the global Medical Nuclide Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Medical Nuclide Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Medical Nuclide Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Nuclide Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Medical Nuclide Products market include China Isotope & Radiation, Dongcheng Pharma, Eli Lilly, Junan Pharmaceutical, Bayer, Siemens, Q BioMed, Progenics Pharmaceuticals and Polatom, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Medical Nuclide Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medical Nuclide Products market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Nuclide Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Nuclide Products.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Medical Nuclide Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medical Nuclide Products Market by Company

China Isotope & Radiation

Dongcheng Pharma

Eli Lilly

Junan Pharmaceutical

Bayer

Siemens

Q BioMed

Progenics Pharmaceuticals

Polatom

NTP Radioisotopes

NRG

Novartis International AG

Nordion

Mundipharma

Monrol

Lantheus Medical Imaging, Inc.

Jubilant Life Sciences

International Isotopes

GE Healthcare

Eckert & Ziegler Strahlen

Curium Pharma

Cardinal Health

Bracco Imaging

Aurobindo Pharma

ANSTO

Acrotech Biopharma.

Medical Nuclide Products Segment by Type

Radiopharmaceuticals

Radioactive Sources

Medical Diagnostic Nuclides

Others

Medical Nuclide Products Segment by Application

Hematological Diseases

Cardiovascular Diseases

Bone and Joint Diseases

Cancer

Others

Medical Nuclide Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Nuclide Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Nuclide Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Nuclide Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Medical Nuclide Products companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Medical Nuclide Products Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Medical Nuclide Products Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Medical Nuclide Products Market Share by Region (2021-2026) Table 4. Global Medical Nuclide Products Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Medical Nuclide Products Market Share by Region (2027-2032) Table 6. Global Medical Nuclide Products Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Medical Nuclide Products Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Medical Nuclide Products Market Size Share by Type (2021-2026) Table 9. Global Medical Nuclide Products Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Medical Nuclide Products Market Size Share Forecasted by Type (2027-2032) Table 11. North America Medical Nuclide Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Medical Nuclide Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Medical Nuclide Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Medical Nuclide Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Medical Nuclide Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Medical Nuclide Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Medical Nuclide Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Medical Nuclide Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Medical Nuclide Products Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Medical Nuclide Products Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Medical Nuclide Products Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Medical Nuclide Products Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Medical Nuclide Products Market Size Share by Application (2021-2026) Table 24. Global Medical Nuclide Products Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Medical Nuclide Products Market Size Share Forecasted by Application (2027-2032) Table 26. North America Medical Nuclide Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Medical Nuclide Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Medical Nuclide Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Medical Nuclide Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Medical Nuclide Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Medical Nuclide Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Medical Nuclide Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Medical Nuclide Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Medical Nuclide Products Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Medical Nuclide Products Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Medical Nuclide Products Industry Trends Table 37. Medical Nuclide Products Industry Drivers Table 38. Medical Nuclide Products Industry Opportunities and Challenges Table 39. Medical Nuclide Products Industry Restraints Table 40. Global Medical Nuclide Products Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Medical Nuclide Products Revenue Market Share by Company (2021-2026) Table 42. Global Medical Nuclide Products Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Medical Nuclide Products Key Company Headquarters & Area Served Table 44. Global Medical Nuclide Products Company, Product Type & Application Table 45. Global Medical Nuclide Products Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Medical Nuclide Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. China Isotope & Radiation Company Information Table 49. China Isotope & Radiation Business Overview Table 50. China Isotope & Radiation Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. China Isotope & Radiation Medical Nuclide Products Product Portfolio Table 52. China Isotope & Radiation Recent Development Table 53. Dongcheng Pharma Company Information Table 54. Dongcheng Pharma Business Overview Table 55. Dongcheng Pharma Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Dongcheng Pharma Medical Nuclide Products Product Portfolio Table 57. Dongcheng Pharma Recent Development Table 58. Eli Lilly Company Information Table 59. Eli Lilly Business Overview Table 60. Eli Lilly Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Eli Lilly Medical Nuclide Products Product Portfolio Table 62. Eli Lilly Recent Development Table 63. Junan Pharmaceutical Company Information Table 64. Junan Pharmaceutical Business Overview Table 65. Junan Pharmaceutical Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Junan Pharmaceutical Medical Nuclide Products Product Portfolio Table 67. Junan Pharmaceutical Recent Development Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Bayer Medical Nuclide Products Product Portfolio Table 72. Bayer Recent Development Table 73. Siemens Company Information Table 74. Siemens Business Overview Table 75. Siemens Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Siemens Medical Nuclide Products Product Portfolio Table 77. Siemens Recent Development Table 78. Q BioMed Company Information Table 79. Q BioMed Business Overview Table 80. Q BioMed Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Q BioMed Medical Nuclide Products Product Portfolio Table 82. Q BioMed Recent Development Table 83. Progenics Pharmaceuticals Company Information Table 84. Progenics Pharmaceuticals Business Overview Table 85. Progenics Pharmaceuticals Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Progenics Pharmaceuticals Medical Nuclide Products Product Portfolio Table 87. Progenics Pharmaceuticals Recent Development Table 88. Polatom Company Information Table 89. Polatom Business Overview Table 90. Polatom Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Polatom Medical Nuclide Products Product Portfolio Table 92. Polatom Recent Development Table 93. NTP Radioisotopes Company Information Table 94. NTP Radioisotopes Business Overview Table 95. NTP Radioisotopes Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. NTP Radioisotopes Medical Nuclide Products Product Portfolio Table 97. NTP Radioisotopes Recent Development Table 98. NRG Company Information Table 99. NRG Business Overview Table 100. NRG Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. NRG Medical Nuclide Products Product Portfolio Table 102. NRG Recent Development Table 103. Novartis International AG Company Information Table 104. Novartis International AG Business Overview Table 105. Novartis International AG Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Novartis International AG Medical Nuclide Products Product Portfolio Table 107. Novartis International AG Recent Development Table 108. Nordion Company Information Table 109. Nordion Business Overview Table 110. Nordion Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Nordion Medical Nuclide Products Product Portfolio Table 112. Nordion Recent Development Table 113. Mundipharma Company Information Table 114. Mundipharma Business Overview Table 115. Mundipharma Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Mundipharma Medical Nuclide Products Product Portfolio Table 117. Mundipharma Recent Development Table 118. Monrol Company Information Table 119. Monrol Business Overview Table 120. Monrol Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Monrol Medical Nuclide Products Product Portfolio Table 122. Monrol Recent Development Table 123. Lantheus Medical Imaging, Inc. Company Information Table 124. Lantheus Medical Imaging, Inc. Business Overview Table 125. Lantheus Medical Imaging, Inc. Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Lantheus Medical Imaging, Inc. Medical Nuclide Products Product Portfolio Table 127. Lantheus Medical Imaging, Inc. Recent Development Table 128. Jubilant Life Sciences Company Information Table 129. Jubilant Life Sciences Business Overview Table 130. Jubilant Life Sciences Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Jubilant Life Sciences Medical Nuclide Products Product Portfolio Table 132. Jubilant Life Sciences Recent Development Table 133. International Isotopes Company Information Table 134. International Isotopes Business Overview Table 135. International Isotopes Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. International Isotopes Medical Nuclide Products Product Portfolio Table 137. International Isotopes Recent Development Table 138. GE Healthcare Company Information Table 139. GE Healthcare Business Overview Table 140. GE Healthcare Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. GE Healthcare Medical Nuclide Products Product Portfolio Table 142. GE Healthcare Recent Development Table 143. Eckert & Ziegler Strahlen Company Information Table 144. Eckert & Ziegler Strahlen Business Overview Table 145. Eckert & Ziegler Strahlen Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Eckert & Ziegler Strahlen Medical Nuclide Products Product Portfolio Table 147. Eckert & Ziegler Strahlen Recent Development Table 148. Curium Pharma Company Information Table 149. Curium Pharma Business Overview Table 150. Curium Pharma Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Curium Pharma Medical Nuclide Products Product Portfolio Table 152. Curium Pharma Recent Development Table 153. Cardinal Health Company Information Table 154. Cardinal Health Business Overview Table 155. Cardinal Health Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Cardinal Health Medical Nuclide Products Product Portfolio Table 157. Cardinal Health Recent Development Table 158. Bracco Imaging Company Information Table 159. Bracco Imaging Business Overview Table 160. Bracco Imaging Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Bracco Imaging Medical Nuclide Products Product Portfolio Table 162. Bracco Imaging Recent Development Table 163. Aurobindo Pharma Company Information Table 164. Aurobindo Pharma Business Overview Table 165. Aurobindo Pharma Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Aurobindo Pharma Medical Nuclide Products Product Portfolio Table 167. Aurobindo Pharma Recent Development Table 168. ANSTO Company Information Table 169. ANSTO Business Overview Table 170. ANSTO Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. ANSTO Medical Nuclide Products Product Portfolio Table 172. ANSTO Recent Development Table 173. Acrotech Biopharma. Company Information Table 174. Acrotech Biopharma. Business Overview Table 175. Acrotech Biopharma. Medical Nuclide Products Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Acrotech Biopharma. Medical Nuclide Products Product Portfolio Table 177. Acrotech Biopharma. Recent Development Table 178. North America Medical Nuclide Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. North America Medical Nuclide Products Market Size by Country (2021-2026) & (US$ Million) Table 180. North America Medical Nuclide Products Market Share by Country (2021-2026) Table 181. North America Medical Nuclide Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. North America Medical Nuclide Products Market Share Forecast by Country (2027-2032) Table 183. Europe Medical Nuclide Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Europe Medical Nuclide Products Market Size by Country (2021-2026) & (US$ Million) Table 185. Europe Medical Nuclide Products Market Share by Country (2021-2026) Table 186. Europe Medical Nuclide Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Europe Medical Nuclide Products Market Share Forecast by Country (2027-2032) Table 188. Asia-Pacific Medical Nuclide Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Asia-Pacific Medical Nuclide Products Market Size by Country (2021-2026) & (US$ Million) Table 190. Asia-Pacific Medical Nuclide Products Market Share by Country (2021-2026) Table 191. Asia-Pacific Medical Nuclide Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Asia-Pacific Medical Nuclide Products Market Share Forecast by Country (2027-2032) Table 193. Latin America Medical Nuclide Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Latin America Medical Nuclide Products Market Size by Country (2021-2026) & (US$ Million) Table 195. Latin America Medical Nuclide Products Market Share by Country (2021-2026) Table 196. Latin America Medical Nuclide Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Latin America Medical Nuclide Products Market Share Forecast by Country (2027-2032) Table 198. Middle East & Africa Medical Nuclide Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East & Africa Medical Nuclide Products Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East & Africa Medical Nuclide Products Market Share by Country (2021-2026) Table 201. Middle East & Africa Medical Nuclide Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East & Africa Medical Nuclide Products Market Share Forecast by Country (2027-2032) Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Medical Nuclide Products Product Image Figure 3. Global Medical Nuclide Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Medical Nuclide Products Market Size (2021-2032) & (US$ Million) Figure 5. Global Medical Nuclide Products Market Share by Region: 2025 VS 2032 Figure 6. Global Medical Nuclide Products Market Share by Region (2021-2032) Figure 7. North America Medical Nuclide Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Medical Nuclide Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Medical Nuclide Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Medical Nuclide Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Medical Nuclide Products Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Radiopharmaceuticals Image Figure 13. Global Radiopharmaceuticals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Radioactive Sources Image Figure 15. Global Radioactive Sources Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Medical Diagnostic Nuclides Image Figure 17. Global Medical Diagnostic Nuclides Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Medical Nuclide Products Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Medical Nuclide Products Market Share by Type 2025 VS 2032 Figure 22. North America Medical Nuclide Products Market Size Share by Type (2021-2032) Figure 23. Europe Medical Nuclide Products Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Medical Nuclide Products Market Size Share by Type (2021-2032) Figure 25. Latin America Medical Nuclide Products Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Medical Nuclide Products Market Size Share by Type (2021-2032) Figure 27. Hematological Diseases Image Figure 28. Global Hematological Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Cardiovascular Diseases Image Figure 30. Global Cardiovascular Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Bone and Joint Diseases Image Figure 32. Global Bone and Joint Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Cancer Image Figure 34. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Medical Nuclide Products Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Medical Nuclide Products Market Share by Application 2025 VS 2032 Figure 39. North America Medical Nuclide Products Market Size Share by Application (2021-2032) Figure 40. Europe Medical Nuclide Products Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Medical Nuclide Products Market Size Share by Application (2021-2032) Figure 42. Latin America Medical Nuclide Products Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Medical Nuclide Products Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Medical Nuclide Products Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Medical Nuclide Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Medical Nuclide Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Medical Nuclide Products Market Share by Country (2021-2032) Figure 49. Europe Medical Nuclide Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Medical Nuclide Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Medical Nuclide Products Market Share by Country (2021-2032) Figure 52. Asia-Pacific Medical Nuclide Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Medical Nuclide Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Medical Nuclide Products Market Share by Country (2021-2032) Figure 55. Latin America Medical Nuclide Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Medical Nuclide Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Medical Nuclide Products Market Share by Country (2021-2032) Figure 58. Middle East & Africa Medical Nuclide Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Medical Nuclide Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Medical Nuclide Products Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Radiopharmaceuticals
  • Radioactive Sources
  • Medical Diagnostic Nuclides
  • Others
Applications
  • Hematological Diseases
  • Cardiovascular Diseases
  • Bone and Joint Diseases
  • Cancer
  • Others
Companies covered
  • China Isotope & Radiation
  • Dongcheng Pharma
  • Eli Lilly
  • Junan Pharmaceutical
  • Bayer
  • Siemens
  • Q BioMed
  • Progenics Pharmaceuticals
  • Polatom
  • NTP Radioisotopes
  • NRG
  • Novartis International AG
  • Nordion
  • Mundipharma
  • Monrol
  • Lantheus Medical Imaging, Inc.
  • Jubilant Life Sciences
  • International Isotopes
  • GE Healthcare
  • Eckert & Ziegler Strahlen
  • Curium Pharma
  • Cardinal Health
  • Bracco Imaging
  • Aurobindo Pharma
  • ANSTO
  • Acrotech Biopharma.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Medical Nuclide Products Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Medical Nuclide Products Market Size by Region (2021-2032)
  5. 1.4.1 Global Medical Nuclide Products Market Size by Region (2021-2026)
  6. 1.4.2 Global Medical Nuclide Products Market Size by Region (2027-2032)
  7. 1.5 Key Regions Medical Nuclide Products Market Size (2021-2032)
  8. 1.5.1 North America Medical Nuclide Products Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Medical Nuclide Products Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Medical Nuclide Products Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Medical Nuclide Products Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Medical Nuclide Products Market Size Growth Rate (2021-2032)
2 Medical Nuclide Products Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Radiopharmaceuticals
  3. 2.1.2 Radioactive Sources
  4. 2.1.3 Medical Diagnostic Nuclides
  5. 2.1.4 Others
  6. 2.2 Global Medical Nuclide Products Market Size by Type
  7. 2.2.1 Global Medical Nuclide Products Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Medical Nuclide Products Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Medical Nuclide Products Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Medical Nuclide Products Market Size by Regions
  11. 2.3.1 North America Medical Nuclide Products Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Medical Nuclide Products Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Medical Nuclide Products Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Medical Nuclide Products Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Medical Nuclide Products Market Size Breakdown by Type (2021-2026)
3 Medical Nuclide Products Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hematological Diseases
  3. 3.1.2 Cardiovascular Diseases
  4. 3.1.3 Bone and Joint Diseases
  5. 3.1.4 Cancer
  6. 3.1.5 Others
  7. 3.2 Global Medical Nuclide Products Market Size by Application
  8. 3.2.1 Global Medical Nuclide Products Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Medical Nuclide Products Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Medical Nuclide Products Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Medical Nuclide Products Market Size by Regions
  12. 3.3.1 North America Medical Nuclide Products Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Medical Nuclide Products Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Medical Nuclide Products Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Medical Nuclide Products Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Medical Nuclide Products Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Medical Nuclide Products Industry Trends
  2. 4.2 Medical Nuclide Products Industry Drivers
  3. 4.3 Medical Nuclide Products Industry Opportunities and Challenges
  4. 4.4 Medical Nuclide Products Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Medical Nuclide Products Revenue (2021-2026)
  2. 5.2 Global Medical Nuclide Products Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Medical Nuclide Products Key Company Headquarters & Area Served
  4. 5.4 Global Medical Nuclide Products Company, Product Type & Application
  5. 5.5 Global Medical Nuclide Products Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Medical Nuclide Products Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Medical Nuclide Products Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Medical Nuclide Products Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 China Isotope & Radiation
  2. 6.1.1 China Isotope & Radiation Company Information
  3. 6.1.2 China Isotope & Radiation Business Overview
  4. 6.1.3 China Isotope & Radiation Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 China Isotope & Radiation Medical Nuclide Products Product Portfolio
  6. 6.1.5 China Isotope & Radiation Recent Developments
  7. 6.2 Dongcheng Pharma
  8. 6.2.1 Dongcheng Pharma Company Information
  9. 6.2.2 Dongcheng Pharma Business Overview
  10. 6.2.3 Dongcheng Pharma Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Dongcheng Pharma Medical Nuclide Products Product Portfolio
  12. 6.2.5 Dongcheng Pharma Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Medical Nuclide Products Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Junan Pharmaceutical
  20. 6.4.1 Junan Pharmaceutical Company Information
  21. 6.4.2 Junan Pharmaceutical Business Overview
  22. 6.4.3 Junan Pharmaceutical Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Junan Pharmaceutical Medical Nuclide Products Product Portfolio
  24. 6.4.5 Junan Pharmaceutical Recent Developments
  25. 6.5 Bayer
  26. 6.5.1 Bayer Company Information
  27. 6.5.2 Bayer Business Overview
  28. 6.5.3 Bayer Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Bayer Medical Nuclide Products Product Portfolio
  30. 6.5.5 Bayer Recent Developments
  31. 6.6 Siemens
  32. 6.6.1 Siemens Company Information
  33. 6.6.2 Siemens Business Overview
  34. 6.6.3 Siemens Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Siemens Medical Nuclide Products Product Portfolio
  36. 6.6.5 Siemens Recent Developments
  37. 6.7 Q BioMed
  38. 6.7.1 Q BioMed Company Information
  39. 6.7.2 Q BioMed Business Overview
  40. 6.7.3 Q BioMed Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Q BioMed Medical Nuclide Products Product Portfolio
  42. 6.7.5 Q BioMed Recent Developments
  43. 6.8 Progenics Pharmaceuticals
  44. 6.8.1 Progenics Pharmaceuticals Company Information
  45. 6.8.2 Progenics Pharmaceuticals Business Overview
  46. 6.8.3 Progenics Pharmaceuticals Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Progenics Pharmaceuticals Medical Nuclide Products Product Portfolio
  48. 6.8.5 Progenics Pharmaceuticals Recent Developments
  49. 6.9 Polatom
  50. 6.9.1 Polatom Company Information
  51. 6.9.2 Polatom Business Overview
  52. 6.9.3 Polatom Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Polatom Medical Nuclide Products Product Portfolio
  54. 6.9.5 Polatom Recent Developments
  55. 6.10 NTP Radioisotopes
  56. 6.10.1 NTP Radioisotopes Company Information
  57. 6.10.2 NTP Radioisotopes Business Overview
  58. 6.10.3 NTP Radioisotopes Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 NTP Radioisotopes Medical Nuclide Products Product Portfolio
  60. 6.10.5 NTP Radioisotopes Recent Developments
  61. 6.11 NRG
  62. 6.11.1 NRG Company Information
  63. 6.11.2 NRG Business Overview
  64. 6.11.3 NRG Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 NRG Medical Nuclide Products Product Portfolio
  66. 6.11.5 NRG Recent Developments
  67. 6.12 Novartis International AG
  68. 6.12.1 Novartis International AG Company Information
  69. 6.12.2 Novartis International AG Business Overview
  70. 6.12.3 Novartis International AG Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Novartis International AG Medical Nuclide Products Product Portfolio
  72. 6.12.5 Novartis International AG Recent Developments
  73. 6.13 Nordion
  74. 6.13.1 Nordion Company Information
  75. 6.13.2 Nordion Business Overview
  76. 6.13.3 Nordion Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Nordion Medical Nuclide Products Product Portfolio
  78. 6.13.5 Nordion Recent Developments
  79. 6.14 Mundipharma
  80. 6.14.1 Mundipharma Company Information
  81. 6.14.2 Mundipharma Business Overview
  82. 6.14.3 Mundipharma Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Mundipharma Medical Nuclide Products Product Portfolio
  84. 6.14.5 Mundipharma Recent Developments
  85. 6.15 Monrol
  86. 6.15.1 Monrol Company Information
  87. 6.15.2 Monrol Business Overview
  88. 6.15.3 Monrol Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Monrol Medical Nuclide Products Product Portfolio
  90. 6.15.5 Monrol Recent Developments
  91. 6.16 Lantheus Medical Imaging, Inc.
  92. 6.16.1 Lantheus Medical Imaging, Inc. Company Information
  93. 6.16.2 Lantheus Medical Imaging, Inc. Business Overview
  94. 6.16.3 Lantheus Medical Imaging, Inc. Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Lantheus Medical Imaging, Inc. Medical Nuclide Products Product Portfolio
  96. 6.16.5 Lantheus Medical Imaging, Inc. Recent Developments
  97. 6.17 Jubilant Life Sciences
  98. 6.17.1 Jubilant Life Sciences Company Information
  99. 6.17.2 Jubilant Life Sciences Business Overview
  100. 6.17.3 Jubilant Life Sciences Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Jubilant Life Sciences Medical Nuclide Products Product Portfolio
  102. 6.17.5 Jubilant Life Sciences Recent Developments
  103. 6.18 International Isotopes
  104. 6.18.1 International Isotopes Company Information
  105. 6.18.2 International Isotopes Business Overview
  106. 6.18.3 International Isotopes Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 International Isotopes Medical Nuclide Products Product Portfolio
  108. 6.18.5 International Isotopes Recent Developments
  109. 6.19 GE Healthcare
  110. 6.19.1 GE Healthcare Company Information
  111. 6.19.2 GE Healthcare Business Overview
  112. 6.19.3 GE Healthcare Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 GE Healthcare Medical Nuclide Products Product Portfolio
  114. 6.19.5 GE Healthcare Recent Developments
  115. 6.20 Eckert & Ziegler Strahlen
  116. 6.20.1 Eckert & Ziegler Strahlen Company Information
  117. 6.20.2 Eckert & Ziegler Strahlen Business Overview
  118. 6.20.3 Eckert & Ziegler Strahlen Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Eckert & Ziegler Strahlen Medical Nuclide Products Product Portfolio
  120. 6.20.5 Eckert & Ziegler Strahlen Recent Developments
  121. 6.21 Curium Pharma
  122. 6.21.1 Curium Pharma Company Information
  123. 6.21.2 Curium Pharma Business Overview
  124. 6.21.3 Curium Pharma Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Curium Pharma Medical Nuclide Products Product Portfolio
  126. 6.21.5 Curium Pharma Recent Developments
  127. 6.22 Cardinal Health
  128. 6.22.1 Cardinal Health Company Information
  129. 6.22.2 Cardinal Health Business Overview
  130. 6.22.3 Cardinal Health Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Cardinal Health Medical Nuclide Products Product Portfolio
  132. 6.22.5 Cardinal Health Recent Developments
  133. 6.23 Bracco Imaging
  134. 6.23.1 Bracco Imaging Company Information
  135. 6.23.2 Bracco Imaging Business Overview
  136. 6.23.3 Bracco Imaging Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Bracco Imaging Medical Nuclide Products Product Portfolio
  138. 6.23.5 Bracco Imaging Recent Developments
  139. 6.24 Aurobindo Pharma
  140. 6.24.1 Aurobindo Pharma Company Information
  141. 6.24.2 Aurobindo Pharma Business Overview
  142. 6.24.3 Aurobindo Pharma Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Aurobindo Pharma Medical Nuclide Products Product Portfolio
  144. 6.24.5 Aurobindo Pharma Recent Developments
  145. 6.25 ANSTO
  146. 6.25.1 ANSTO Company Information
  147. 6.25.2 ANSTO Business Overview
  148. 6.25.3 ANSTO Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 ANSTO Medical Nuclide Products Product Portfolio
  150. 6.25.5 ANSTO Recent Developments
  151. 6.26 Acrotech Biopharma.
  152. 6.26.1 Acrotech Biopharma. Company Information
  153. 6.26.2 Acrotech Biopharma. Business Overview
  154. 6.26.3 Acrotech Biopharma. Medical Nuclide Products Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Acrotech Biopharma. Medical Nuclide Products Product Portfolio
  156. 6.26.5 Acrotech Biopharma. Recent Developments
7 North America
  1. 7.1 North America Medical Nuclide Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Medical Nuclide Products Market Size by Country (2021-2026)
  3. 7.3 North America Medical Nuclide Products Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Medical Nuclide Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Medical Nuclide Products Market Size by Country (2021-2026)
  3. 8.3 Europe Medical Nuclide Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Medical Nuclide Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Medical Nuclide Products Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Medical Nuclide Products Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Medical Nuclide Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Medical Nuclide Products Market Size by Country (2021-2026)
  3. 10.3 South America Medical Nuclide Products Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Medical Nuclide Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Medical Nuclide Products Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Medical Nuclide Products Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst